Ethics, marketing, and the medical literature [1]

Anesthesia and Analgesia

Volumn 103, Issue 2, 2006, Pages 488-

  Mychaskiw II, George ^a   Badr, Ahmed E ^a   Calimaran, Arthur M ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANZAMET; DOLASETRON MESILATE; ONDANSETRON;

CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG MARKETING; LETTER; MEDICAL ETHICS; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION;

EID: 33746574585     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000227075.06595.3A     Document Type: Letter

References (4)

1. White PF. Treatment of postoperative nausea and vomiting with dolasetron versus ondansetron: is there a conflict of interest? Anesth Analg 2005;101:1887.
2. Roberson CR, Meyer TA. In response. Anesth Analg 2005;101:1887-8.
3. Meyer TA, Roberson CR, Rajab MH, et al. Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting. Anesth Analg 2005;100:373-7.
4. Mychaskiw G, Badr AE. Case series or uncontrolled clinical study? Anesthesiology 2005;102:1066.